AHA Urges FDA to Adopt Risk-Based Oversight for AI-Enabled Medical Devices

The American Hospital Association (AHA) has called on the FDA to implement risk-based regulatory oversight for artificial intelligence-enabled medical devices. This regulatory guidance is significant for HTM professionals managing next-generation medical technology.